Adenosine deaminase and adenosine receptor polymorphisms in aspirin-intolerant asthma

Respiratory Medicine

Volumn 103, Issue 3, 2009, Pages 356-363

  Kim, Sang Heon ^a   Kim, Yoon Keun ^b   Park, Heung Woo ^c   Kim, Sang Hoon ^d   Kim, Seung Hyun ^e   Ye, Young Min ^e   Min, Kyung Up ^c   Park, Hae Sim ^e  

^a Hanyang University College of Medicine   (South Korea)

^b Pohang University of Science and Technology (POSTECH)   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Eulji University   (South Korea)

^e Ajou University School of Medicine   (South Korea)

Author keywords

Adenosine deaminase; Adenosine receptors; Aspirin intolerant asthma; Polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ADENOSINE A2B RECEPTOR; ADENOSINE A3 RECEPTOR; ADENOSINE DEAMINASE; ADENOSINE RECEPTOR;

ADORA1 GENE; ADORA2A GENE; ADORA2B GENE; ADORA3 GENE; ADULT; ARTICLE; ASTHMA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENE FREQUENCY; GENE SEQUENCE; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOSINE DEAMINASE; ADULT; ASPIRIN; ASTHMA; BRONCHIAL PROVOCATION TESTS; CASE-CONTROL STUDIES; DRUG HYPERSENSITIVITY; DRUG TOLERANCE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LOGISTIC MODELS; LUNG; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTOR, ADENOSINE A2B; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1;

EID: 59349094942     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.10.008     Document Type: Article

References (44)

1. Szczeklik A., Nizankowska E., and Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European network on aspirin-induced asthma. Eur Respir J 16 3 (2000) 432-436
2. Kim S.H., and Park H.S. Pathogenesis of nonsteroidal antiinflammatory drug-induced asthma. Curr Opin Allergy Clin Immunol 6 1 (2006) 17-22
3. Kim S.H., Hur G.Y., Choi J.H., and Park H.S. Pharmacogenetics of aspirin-intolerant asthma. Pharmacogenomics 9 1 (2008) 85-91
4. Sitkovsky M.V., Lukashev D., Apasov S., Kojima H., Koshiba M., Caldwell C., et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors. Annu Rev Immunol 22 (2004) 657-682
5. Csoma Z., Huszar E., Vizi E., Vass G., Szabo Z., Herjavecz I., et al. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction. Eur Respir J 25 5 (2005) 873-878
6. Mann J.S., Holgate S.T., Renwick A.G., and Cushley M.J. Airway effects of purine nucleosides and nucleotides and release with bronchial provocation in asthma. J Appl Physiol 61 5 (1986) 1667-1676
7. Driver A.G., Kukoly C.A., Ali S., and Mustafa S.J. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148 1 (1993) 91-97
8. Cushley M.J., Tattersfield A.E., and Holgate S.T. Inhaled adenosine and guanosine on airway resistance in normal and asthmatic subjects. Br J Clin Pharmacol 15 2 (1983) 161-165
9. Fredholm B.B., IJzerman A.P., Jacobson K.A., Klotz K.N., and Linden J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53 4 (2001) 527-552
10. Rorke S., and Holgate S.T. Targeting adenosine receptors: novel therapeutic targets in asthma and chronic obstructive pulmonary disease. Am J Respir Med 1 2 (2002) 99-105
11. Blackburn M.R., Volmer J.B., Thrasher J.L., Zhong H., Crosby J.R., Lee J.J., et al. Metabolic consequences of adenosine deaminase deficiency in mice are associated with defects in alveogenesis, pulmonary inflammation, and airway obstruction. J Exp Med 192 2 (2000) 159-170
12. Crimi N., Polosa R., Magri S., Prosperini G., Milazzo V.L., Santonocito G., et al. Inhaled lysine acetylsalicylate (L-ASA) attenuates the bronchoconstrictor response to adenosine 5′-monophosphate (AMP) in asthmatic subjects. Eur Respir J 8 6 (1995) 905-912
13. Cronstein B.N., Montesinos M.C., and Weissmann G. Salicylates and sulfasalazine, but not glucocorticoids, inhibit leukocyte accumulation by an adenosine-dependent mechanism that is independent of inhibition of prostaglandin synthesis and p105 of NFkappaB. Proc Natl Acad Sci U S A 96 11 (1999) 6377-6381
14. Cronstein B.N., Montesinos M.C., and Weissmann G. Sites of action for future therapy: an adenosine-dependent mechanism by which aspirin retains its antiinflammatory activity in cyclooxygenase-2 and NFkappaB knockout mice. Osteoarthritis Cartilage 7 4 (1999) 361-363
15. Cronstein B.N., Van de Stouwe M., Druska L., Levin R.I., and Weissmann G. Nonsteroidal antiinflammatory agents inhibit stimulated neutrophil adhesion to endothelium: adenosine dependent and independent mechanisms. Inflammation 18 3 (1994) 323-335
16. Odashima M., Otaka M., Jin M., Komatsu K., Wada I., Horikawa Y., et al. Attenuation of gastric mucosal inflammation induced by aspirin through activation of A2A adenosine receptor in rats. World J Gastroenterol 12 4 (2006) 568-573
17. Gloria-Bottini F., Ronchetti F., Ammendola L., and Bottini N. Adenosine deaminase polymorphism and the relationship of total immunoglobulin E with skin prick test: a study on school children. Allergy Asthma Proc 27 2 (2006) 115-118
18. Liu Y., Saccucci P., Qi H., Wu H.C., Zhao F., Dai Y., et al. ADA polymorphisms and asthma: a study in the Chinese Han population. J Asthma 43 3 (2006) 203-206
19. Ronchetti R., Lucarini N., Lucarelli P., Martinez F., Macri F., Carapella E., et al. A genetic basis for heterogeneity of asthma syndrome in pediatric ages: adenosine deaminase phenotypes. J Allergy Clin Immunol 74 1 (1984) 81-84
20. Popa V. ATS guidelines for methacholine and exercise challenge testing. Am J Respir Crit Care Med 163 1 (2001) 292-293
21. Choi J.H., Park H.S., Oh H.B., Lee J.H., Suh Y.J., Park C.S., et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 114 4 (2004) 337-344
22. Park H.S. Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. Clin Exp Allergy 25 1 (1995) 38-40
23. Han W., Kang D., Park I.A., Kim S.W., Bae J.Y., Chung K.W., et al. Associations between breast cancer susceptibility gene polymorphisms and clinicopathological features. Clin Cancer Res 10 1 Pt 1 (2004) 124-130
24. Sanak M., Simon H.U., and Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 350 9091 (1997) 1599-1600
25. Park J.S., Chang H.S., Park C.S., Lee J.H., Lee Y.M., Choi J.H., et al. Association analysis of cysteinyl-leukotriene receptor 2 (CYSLTR2) polymorphisms with aspirin intolerance in asthmatics. Pharmacogenet Genomics 15 7 (2005) 483-492
26. Kim S.H., Choi J.H., Park H.S., Holloway J.W., Lee S.K., Park C.S., et al. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma. Clin Exp Allergy 35 5 (2005) 585-590
27. Kim S.H., Kim Y.K., Park H.W., Jee Y.K., Kim S.H., Bahn J.W., et al. Association between polymorphisms in prostanoid receptor genes and aspirin-intolerant asthma. Pharmacogenet Genomics 17 4 (2007) 295-304
28. Brown R.A., Clarke G.W., Ledbetter C.L., Hurle M.J., Denyer J.C., Simcock D.E., et al. Elevated expression of adenosine A1 receptor in bronchial biopsy specimens from asthmatic subjects. Eur Respir J 31 2 (2008) 311-319
29. Bjorck T., Gustafsson L.E., and Dahlen S.E. Isolated bronchi from asthmatics are hyperresponsive to adenosine, which apparently acts indirectly by liberation of leukotrienes and histamine. Am Rev Respir Dis 145 5 (1992) 1087-1091
30. Nyce J.W., and Metzger W.J. DNA antisense therapy for asthma in an animal model. Nature 385 6618 (1997) 721-725
31. Obiefuna P.C., Batra V.K., Nadeem A., Borron P., Wilson C.N., and Mustafa S.J. A novel A1 adenosine receptor antagonist, L-97-1 [3-[2-(4-aminophenyl)-ethyl]-8-benzyl-7-{2-ethyl-(2-hydroxy-ethyl)-amino]-ethyl}-1-propyl-3,7-dihydro-purine-2,6-dione], reduces allergic responses to house dust mite in an allergic rabbit model of asthma. J Pharmacol Exp Ther 315 1 (2005) 329-336
32. Cronstein B.N., Levin R.I., Philips M., Hirschhorn R., Abramson S.B., and Weissmann G. Neutrophil adherence to endothelium is enhanced via adenosine A1 receptors and inhibited via adenosine A2 receptors. J Immunol 148 7 (1992) 2201-2206
33. Sun C.X., Young H.W., Molina J.G., Volmer J.B., Schnermann J., and Blackburn M.R. A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury. J Clin Invest 115 1 (2005) 35-43
34. Chen J.M., Ferec C., and Cooper D.N. A systematic analysis of disease-associated variants in the 3′ regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3′ UTR variants. Hum Genet 120 3 (2006) 301-333
35. Tang Z., Diamond M.A., Chen J.M., Holly T.A., Bonow R.O., Dasgupta A., et al. Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy. Clin Pharmacol Ther 82 4 (2007) 435-440
36. Cronstein B.N., Rosenstein E.D., Kramer S.B., Weissmann G., and Hirschhorn R. Adenosine: a physiologic modulator of superoxide anion generation by human neutrophils. Adenosine acts via an A2 receptor on human neutrophils. J Immunol 135 2 (1985) 1366-1371
37. Hughes P.J., Holgate S.T., and Church M.K. Adenosine inhibits and potentiates IgE-dependent histamine release from human lung mast cells by an A2-purinoceptor mediated mechanism. Biochem Pharmacol 33 23 (1984) 3847-3852
38. Fozard J.R., Ellis K.M., Villela Dantas M.F., Tigani B., and Mazzoni L. Effects of CGS 21680, a selective adenosine A2A receptor agonist, on allergic airways inflammation in the rat. Eur J Pharmacol 438 3 (2002) 183-188
39. Nadeem A., Fan M., Ansari H.R., Ledent C., and Jamal Mustafa S. Enhanced airway reactivity and inflammation in A2A adenosine receptor-deficient allergic mice. Am J Physiol Lung Cell Mol Physiol 292 6 (2007) L1335-L1344
40. Mustafa S.J., Nadeem A., Fan M., Zhong H., Belardinelli L., and Zeng D. Effect of a specific and selective A(2B) adenosine receptor antagonist on adenosine agonist AMP and allergen-induced airway responsiveness and cellular influx in a mouse model of asthma. J Pharmacol Exp Ther 320 3 (2007) 1246-1251
41. Tang C.M., Hoerning A., Buscher R., O'Connor D.T., Ratjen F., Grasemann H., et al. Human adenosine 2B receptor: SNP discovery and evaluation of expression in patients with cystic fibrosis. Pharmacogenet Genomics 15 5 (2005) 321-327
42. Walker B.A., Jacobson M.A., Knight D.A., Salvatore C.A., Weir T., Zhou D., et al. Adenosine A3 receptor expression and function in eosinophils. Am J Respir Cell Mol Biol 16 5 (1997) 531-537
43. Ezeamuzie C.I., and Philips E. Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release. Br J Pharmacol 127 1 (1999) 188-194
44. Young H.W., Molina J.G., Dimina D., Zhong H., Jacobson M., Chan L.N., et al. A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice. J Immunol 173 2 (2004) 1380-1389